Literature DB >> 33504901

Brain structural and functional substrates of ADGRL3 (latrophilin 3) haplotype in attention-deficit/hyperactivity disorder.

Ana Moreno-Alcázar1,2,3,4, Josep A Ramos-Quiroga4,5,6,7, Marta Ribases4,6,7,8, Cristina Sánchez-Mora4,6,7,8, Gloria Palomar7, Rosa Bosch4,5,6,7, Josep Salavert1,4,5,9, Lydia Fortea4,10,11, Gemma C Monté-Rubio1,4,11, Erick J Canales-Rodríguez1,4,12, Michael P Milham13,14, F Xavier Castellanos13,15, Miquel Casas4,5,6,7, Edith Pomarol-Clotet16,17, Joaquim Radua18,19,20,21,22.   

Abstract

Previous studies have shown that the gene encoding the adhesion G protein-coupled receptor L3 (ADGRL3; formerly latrophilin 3, LPHN3) is associated with Attention-Deficit/Hyperactivity Disorder (ADHD). Conversely, no studies have investigated the anatomical or functional brain substrates of ADGRL3 risk variants. We examined here whether individuals with different ADGRL3 haplotypes, including both patients with ADHD and healthy controls, showed differences in brain anatomy and function. We recruited and genotyped adult patients with combined type ADHD and healthy controls to achieve a sample balanced for age, sex, premorbid IQ, and three ADGRL3 haplotype groups (risk, protective, and others). The final sample (n = 128) underwent structural and functional brain imaging (voxel-based morphometry and n-back working memory fMRI). We analyzed the brain structural and functional effects of ADHD, haplotypes, and their interaction, covarying for age, sex, and medication. Individuals (patients or controls) with the protective haplotype showed strong, widespread hypo-activation in the frontal cortex extending to inferior temporal and fusiform gyri. Individuals (patients or controls) with the risk haplotype also showed hypo-activation, more focused in the right temporal cortex. Patients showed parietal hyper-activation. Disorder-haplotype interactions, as well as structural findings, were not statistically significant. To sum up, both protective and risk ADGRL3 haplotypes are associated with substantial brain hypo-activation during working memory tasks, stressing this gene's relevance in cognitive brain function. Conversely, we did not find brain effects of the interactions between adult ADHD and ADGRL3 haplotypes.

Entities:  

Year:  2021        PMID: 33504901      PMCID: PMC7840726          DOI: 10.1038/s41598-021-81915-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication.

Authors:  Tomohiro Nakao; Joaquim Radua; Katya Rubia; David Mataix-Cols
Journal:  Am J Psychiatry       Date:  2011-08-24       Impact factor: 18.112

Review 2.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

3.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.

Authors:  M Arcos-Burgos; M Jain; M T Acosta; S Shively; H Stanescu; D Wallis; S Domené; J I Vélez; J D Karkera; J Balog; K Berg; R Kleta; W A Gahl; E Roessler; R Long; J Lie; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; S Johansson; P M Knappskog; J Haavik; M Ribases; B Cormand; M Bayes; M Casas; J A Ramos-Quiroga; A Hervas; B S Maher; S V Faraone; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; A Vortmeyer; J E Bailey-Wilson; F X Castellanos; M Muenke
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

4.  LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.

Authors:  E M Bruxel; A Salatino-Oliveira; G C Akutagava-Martins; L Tovo-Rodrigues; J P Genro; C P Zeni; G V Polanczyk; R Chazan; M Schmitz; M Arcos-Burgos; L A Rohde; M H Hutz
Journal:  Genes Brain Behav       Date:  2015-06       Impact factor: 3.449

Review 5.  Attention-deficit/hyperactivity disorder: a selective overview.

Authors:  Joseph Biederman
Journal:  Biol Psychiatry       Date:  2004-12-18       Impact factor: 13.382

6.  Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative.

Authors:  Carmen Lara; John Fayyad; Ron de Graaf; Ronald C Kessler; Sergio Aguilar-Gaxiola; Matthias Angermeyer; Koen Demytteneare; Giovanni de Girolamo; Josep Maria Haro; Robert Jin; Elie G Karam; Jean-Pierre Lépine; Maria Elena Medina Mora; Johan Ormel; José Posada-Villa; Nancy Sampson
Journal:  Biol Psychiatry       Date:  2008-11-12       Impact factor: 13.382

7.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

Authors:  Ditte Demontis; Raymond K Walters; Joanna Martin; Manuel Mattheisen; Thomas D Als; Esben Agerbo; Gísli Baldursson; Rich Belliveau; Jonas Bybjerg-Grauholm; Marie Bækvad-Hansen; Felecia Cerrato; Kimberly Chambert; Claire Churchhouse; Ashley Dumont; Nicholas Eriksson; Michael Gandal; Jacqueline I Goldstein; Katrina L Grasby; Jakob Grove; Olafur O Gudmundsson; Christine S Hansen; Mads Engel Hauberg; Mads V Hollegaard; Daniel P Howrigan; Hailiang Huang; Julian B Maller; Alicia R Martin; Nicholas G Martin; Jennifer Moran; Jonatan Pallesen; Duncan S Palmer; Carsten Bøcker Pedersen; Marianne Giørtz Pedersen; Timothy Poterba; Jesper Buchhave Poulsen; Stephan Ripke; Elise B Robinson; F Kyle Satterstrom; Hreinn Stefansson; Christine Stevens; Patrick Turley; G Bragi Walters; Hyejung Won; Margaret J Wright; Ole A Andreassen; Philip Asherson; Christie L Burton; Dorret I Boomsma; Bru Cormand; Søren Dalsgaard; Barbara Franke; Joel Gelernter; Daniel Geschwind; Hakon Hakonarson; Jan Haavik; Henry R Kranzler; Jonna Kuntsi; Kate Langley; Klaus-Peter Lesch; Christel Middeldorp; Andreas Reif; Luis Augusto Rohde; Panos Roussos; Russell Schachar; Pamela Sklar; Edmund J S Sonuga-Barke; Patrick F Sullivan; Anita Thapar; Joyce Y Tung; Irwin D Waldman; Sarah E Medland; Kari Stefansson; Merete Nordentoft; David M Hougaard; Thomas Werge; Ole Mors; Preben Bo Mortensen; Mark J Daly; Stephen V Faraone; Anders D Børglum; Benjamin M Neale
Journal:  Nat Genet       Date:  2018-11-26       Impact factor: 38.330

8.  Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility.

Authors:  E M Bruxel; C R Moreira-Maia; G C Akutagava-Martins; T P Quinn; M Klein; B Franke; M Ribasés; P Rovira; C Sánchez-Mora; D B Kappel; N R Mota; E H Grevet; C H D Bau; M Arcos-Burgos; L A Rohde; M H Hutz
Journal:  Mol Psychiatry       Date:  2020-02-12       Impact factor: 13.437

9.  Shared genetic background between children and adults with attention deficit/hyperactivity disorder.

Authors:  Paula Rovira; Ditte Demontis; Anders D Børglum; Barbara Franke; Josep Antoni Ramos-Quiroga; María Soler Artigas; Marta Ribasés; Cristina Sánchez-Mora; Tetyana Zayats; Marieke Klein; Nina Roth Mota; Heike Weber; Iris Garcia-Martínez; Mireia Pagerols; Laura Vilar-Ribó; Lorena Arribas; Vanesa Richarte; Montserrat Corrales; Christian Fadeuilhe; Rosa Bosch; Gemma Español Martin; Peter Almos; Alysa E Doyle; Eugenio Horacio Grevet; Oliver Grimm; Anne Halmøy; Martine Hoogman; Mara Hutz; Christian P Jacob; Sarah Kittel-Schneider; Per M Knappskog; Astri J Lundervold; Olga Rivero; Diego Luiz Rovaris; Angelica Salatino-Oliveira; Bruna Santos da Silva; Evgeniy Svirin; Emma Sprooten; Tatyana Strekalova; Alejandro Arias-Vasquez; Edmund J S Sonuga-Barke; Philip Asherson; Claiton Henrique Dotto Bau; Jan K Buitelaar; Bru Cormand; Stephen V Faraone; Jan Haavik; Stefan E Johansson; Jonna Kuntsi; Henrik Larsson; Klaus-Peter Lesch; Andreas Reif; Luis Augusto Rohde; Miquel Casas
Journal:  Neuropsychopharmacology       Date:  2020-04-12       Impact factor: 7.853

Review 10.  Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.

Authors:  C Bonvicini; S V Faraone; C Scassellati
Journal:  Mol Psychiatry       Date:  2016-05-24       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.